RECRUITING

Patient Controlled Administration of Liquid Acetaminophen

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is a proof of concept pilot study investigating the feasibility and acceptability of patient controlled oral medication administration, using the commonly used and low risk medication in the hospital, oral acetaminophen.

Official Title

Patient Controlled Self-Administration of Oral Liquid Medication: Acetaminophen Trial

Quick Facts

Study Start:2024-11-19
Study Completion:2025-08
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06498713

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Adult patients older than 18 years old admitted to SRC for total shoulder and reverse total shoulder arthroplasty
  2. * The nurse who will administer acetaminophen to a study patient.
  1. * Pregnant patient
  2. * Patients that cannot swallow pills or cannot take liquid (for example due to risk of aspiration)
  3. * Emergency surgery
  4. * Chronic pain
  5. * On home opioids, any other pain modulating medications including benzodiazepine, Neurontin, ketamine.
  6. * Past medical or social history of substance abuse disorder, including ethanol misuse disorder, marijuana misuse disorder
  7. * History of any psychiatric disorders including anxiety, depression, any cognitive dysfunction
  8. * Any patients who cannot provide informed consents on their own (those who would need Legally Authorized Representatives (LARs) or surrogates)
  9. * Liver dysfunction limiting amount of safe oral acetaminophen
  10. * baseline hyperbilirubinemia (ex: chronic liver disease, Gilbert's)
  11. * patients unable to take PO
  12. * Patients with neurologic, neuromuscular, or movement disorders unable to drink from a cup.
  13. * any nurse who is not involved in the direct care of a study patient, or who is not comfortable with setting up the PCA pump.

Contacts and Locations

Study Contact

Jinlei Li, MD, PhD
CONTACT
475-434-4038
jinlei.li@yale.edu

Principal Investigator

Jinlei Li, MD, PhD
PRINCIPAL_INVESTIGATOR
Yale University

Study Locations (Sites)

Yale New Haven Hospital at St. Raphael's Campus
New Haven, Connecticut, 06520
United States

Collaborators and Investigators

Sponsor: Yale University

  • Jinlei Li, MD, PhD, PRINCIPAL_INVESTIGATOR, Yale University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-11-19
Study Completion Date2025-08

Study Record Updates

Study Start Date2024-11-19
Study Completion Date2025-08

Terms related to this study

Keywords Provided by Researchers

  • Pain Management

Additional Relevant MeSH Terms

  • Pain
  • Pain, Postoperative